Hayat Pharmaceutical Industries CoAMM:HPIC 79 Interest Coverage is 4.55 as of Mar. 2026, which is 86% below its 10-year median of 32.46. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 684 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 54.68% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Hayat Pharmaceutical Industries Co's
Operating Income
for the
three
months ended in Mar. 2026 was JOD0.14 Mil. Hayat Pharmaceutical Industries Co's Interest Expense for the
three
months ended in Mar. 2026 was JOD-0.03 Mil.
Hayat Pharmaceutical Industries Co's interest coverage for the quarter that ended in Mar. 2026 was 4.55.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Hayat Pharmaceutical Industries Co's Interest Coverage or its related term are showing as below:
AMM:HPIC'
s Interest Coverage Range Over the Past 10 Years
Min: 15.69 Med: 32.46 Max: 59.31
Current: 15.69
AMM:HPIC's Interest Coverage is ranked better than 54.68% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs AMM:HPIC: 15.69
Hayat Pharmaceutical Industries Co (AMM:HPIC) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Hayat Pharmaceutical Industries Co Interest Coverage Related Terms
Hayat Pharmaceutical Industries Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Hayat Pharmaceutical Industries Co Interest Coverage Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Interest Coverage falls into.
Hayat Pharmaceutical Industries Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Interest Coverage of 4.55 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 86% below median its historical median of 32.46. Over the past decade, Hayat Pharmaceutical Industries Co's Interest Coverage has ranged from 15.69 to 59.31. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #310 out of 684 companies in the Drug Manufacturers industry, placing it in the top 45.3%.
Is Hayat Pharmaceutical Industries Co's Interest Coverage too high?
Hayat Pharmaceutical Industries Co's current Interest Coverage of 4.55 is 86% below median its 10-year median of 32.46. Over the past 10 years, this metric has ranged from a low of 15.69 to a high of 59.31. The Drug Manufacturers industry median Interest Coverage is 12.77. Hayat Pharmaceutical Industries Co's value of 4.55 is 64.4% below this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #310 out of 684 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #310 out of 684 companies for Interest Coverage. This puts Hayat Pharmaceutical Industries Co in the upper half of its industry. The industry median Interest Coverage is 12.77. Hayat Pharmaceutical Industries Co's value of 4.55 is 64.4% below this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Interest Coverage has ranged from 15.69 to 59.31 over the past decade. While the company's 10-year median is 32.46 vs. the industry median of 12.77, Hayat Pharmaceutical Industries Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Interest Coverage of 4.55 is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Interest Coverage is 4.55, which is 86% below median its own 10-year median of 32.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current Interest Coverage is 4.55, which is 86% below median its 10-year median of 32.46 and 64.4% below the Drug Manufacturers industry median of 12.77. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Interest Coverage is 4.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued.
The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74.
GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.
Key valuation signals for AMM:HPIC:
Interest Coverage: 4.55 (86% below median its 10-year median of 32.46)
GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
Industry Position: 64.4% below the Drug Manufacturers median (#310 of 684)
No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score
Get the complete analysis for AMM:HPIC
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
